Stockreport

Myriad Genetics Announces Incorporation of its Proprietary HRD platform in Illumina’s Updated Comprehensive Gene Panel Assay, TruSight™ Oncology 500 v2

Myriad Genetics, Inc.  (MYGN) 
Last myriad genetics, inc. earnings: 2/6 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: myriad.com/news-center/investor-information
PDF SALT LAKE CITY, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, announced updates to its ag [Read more]